feed
S&P 500
NASDAQ
DOW
VIX
US10Y
EUR/USD
GOLD
WTI
BTC
AArphra

HLN

Haleon plc
HealthcareDrug Manufacturers - Specialty & GenericGBUSDCountry macro →
$8.72
LiveJun 03, 2026
AI Brief
Market cap
$38.72B
52w range
8.65 – 11.28
P / E
EPS
Volume
6.61M
Revenue · FY

Explain this page

Arphra AI

Company profile

DB · companies + sec_company_profile + company_profiles

Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Brentford, the United Kingdom.

Headquarters
Building 5, Weybridge, KT13 0NY
GB
Phone
44 1932 822000
AI description
Arphra AI
Loading cached description…

Identifiers

  • SymbolHLN
  • Legal nameHaleon plc
  • CEOBrian James McNamara
  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CountryGB
  • CurrencyUSD
  • ExchangeNYSE
  • IPO dateJul 25, 2022
  • CIK0001900304
  • ISINUS4055521003
  • CUSIP405552100
  • LEI
  • Employees24,561

Trading

DB · key_metrics_ttm
  • Market cap$38.61B
  • P/E (TTM)
  • P/B
  • EV / EBITDA
  • Dividend yield

Identifiers

OpenFIGI · GLEIF

Cross-source keys used to bridge market-data, SEC, and non-US sources.

  • FIGIBBG018GZNCH6
  • CountryGB